MetaCap

Standard BioTools (LAB) vs Precipio (PRPO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

Precipio (PRPO) has outperformed Standard BioTools (LAB) over the past year, gaining 25.5% versus a loss of 47.8%. Over five years, PRPO leads with a -54.1% price change compared with -87.3% for LAB. Standard BioTools is the larger company by market cap ($266.4 million vs $42.1 million), about 6.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LAB-47.79%PRPO+25.47%
+79%+11%-57%
Oct 7, 20251 yearOct 7, 2026
LAB-87.36%PRPO-53.88%
+5%-45%-95%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LAB versus PRPO key metrics
MetricLABPRPO
Share price$0.6787$23.52
Market cap$266.44M$42.11M
1-day change-6.00%+0.30%
YTD return-46.98%+2.35%
1-year return-47.79%+25.47%
5-year return-87.29%-54.06%
Forward P/E—60.31
EPS (TTM)$-0.13$-0.64
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.72$33.63
52-week low$0.63$16.40
Distance from 52-week high-60.54%-30.06%
Average volume1.57M127.81K
Shares outstanding392.58M1.79M
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Standard BioTools is about 6.3 times larger than Precipio by market value ($266.44M vs $42.11M).
  • PRPO has outperformed LAB by 73.3 percentage points over the past year.

LAB vs PRPO FAQ

Which is bigger, Standard BioTools or Precipio?

Standard BioTools (LAB) is larger, with a market capitalization of $266.44M compared with $42.11M for Precipio (PRPO).

Which stock has performed better over the past year, LAB or PRPO?

PRPO returned +25.47% over the past 12 months, compared with -47.79% for LAB (price return, excluding dividends). Past performance does not predict future results.

Are Standard BioTools and Precipio in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons